Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00005622 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Multiple Myeloma and Malignant Plasma Cell Neoplasms
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG: cyclophosphamide
RADIATION: TBI

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]